A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...

Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...

November 7, 2025: With one Blue Protocol code having expired, another new code is here to take its place with the usual collection of Revive Candy, Advance Books, and Sea Breeze gifts. What are the ...

And yes, we're really excited not only with the performance we're seeing in terms of the number of enrollments coming in, but ...

Higher gross profit margin despite lower revenue and profit Group revenue declined 9.0% to US$991.1 million Gross profit margin improved from 31.5% to ...

This reflects 31% growth over the same period last year and marks our thirtieth consecutive quarter of sequential revenue ...

Operator: Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.

Good afternoon, ladies and gentlemen, and welcome to the Inovio Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Monday, November 10, 2025.

Q3 2025 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...

HOUSTON -- A conservative dialysis strategy improved rates of kidney function compared to conventional thrice-weekly dialysis in patients with acute kidney injury (AKI) undergoing kidney replacement ...

WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...